SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P50
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -30.57% |
| 2024 | -36.52% |
| 2023 | -7.08% |
| 2022 | -1280.73% |
| 2021 | -80.14% |
| 2020 | 208.58% |
| 2019 | 0.00% |